8-KOther EventsExhibits & Filings

UNITEDHEALTH GROUP INC 8-K Report, Corporate Update (Dec 8, 2014)

Filed December 8, 2014For Securities:UNH

Summary

UnitedHealth Group Inc. (UNH) filed an 8-K report on December 7, 2014, detailing the issuance of new senior notes. On December 3, 2014, the company entered into an underwriting agreement to sell a total of $2.0 billion in aggregate principal amount of notes across three tranches: $750 million of 1.400% Notes due 2017, $500 million of 2.300% Notes due 2019, and $750 million of 2.875% Notes due 2021. These notes were issued on December 8, 2014, under an existing indenture and were registered under the company's shelf registration statement. The primary purpose of this filing is to report the details of this debt offering, which provides the company with significant capital. Investors should note the specific interest rates and maturity dates associated with each tranche of notes, as these represent new debt obligations for UnitedHealth Group.

Key Highlights

  • 1UnitedHealth Group issued $2.0 billion in aggregate principal amount of new senior notes.
  • 2The notes are divided into three tranches: $750 million (1.400% due 2017), $500 million (2.300% due 2019), and $750 million (2.875% due 2021).
  • 3The debt offering was executed under an underwriting agreement dated December 3, 2014.
  • 4The notes were issued on December 8, 2014, and registered under a Form S-3 shelf registration statement.
  • 5This debt issuance signifies UnitedHealth Group's active capital management and fundraising efforts.
  • 6The filing includes various exhibits such as the underwriting agreement, pricing agreement, officers' certificates, and legal opinions.

Frequently Asked Questions

UnitedHealth Group issued a total of $2.0 billion in aggregate principal amount of new senior notes.

The new notes have the following terms: $750 million of 1.400% Notes due December 15, 2017; $500 million of 2.300% Notes due December 15, 2019; and $750 million of 2.875% Notes due December 15, 2021.

While the filing does not explicitly state the purpose, debt issuances of this magnitude are typically used for general corporate purposes, which can include funding operations, acquisitions, refinancing existing debt, or investing in growth initiatives. This provides the company with substantial capital for strategic objectives.

More details can be found in the exhibits filed with this 8-K report, including the Underwriting Agreement, Pricing Agreement, Officers’ Certificates and Company Orders for each note series, and legal opinions regarding the validity of the notes.